• Explore /
  • Poster
  • / HCRN GI16-288: A phase II trial of perioperative CV301 vaccination in combination with nivolumab and systemic chemotherapy for resectable hepatic-limited metastatic colorectal cancer—Preliminary efficacy and correlative results.

HCRN GI16-288: A phase II trial of perioperative CV301 vaccination in combination with nivolumab and systemic chemotherapy for resectable hepatic-limited metastatic colorectal cancer—Preliminary efficacy and correlative results.

Abstract Poster

Authors

null

Kristen Renee Spencer

Perlmutter Cancer Center of NYU Langone Health/NYU Grossman School of Medicine, New York, NY;

Kristen Renee Spencer , Howard S. Hochster , Patrick M Boland , Lyudmyla Derby Berim , Timothy Kennedy , Miral Grandhi , Russell C Langan , Dirk F. Moore , Michael P. Kane , Smitha S. Krishnamurthi , Skye C. Mayo , Anup Kasi , Agustin Pimentel , Darren R. Carpizo

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Colorectal Cancer,Anal Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT03547999

Citation

J Clin Oncol 41, 2023 (suppl 4; abstr 103)

DOI

10.1200/JCO.2023.41.4_suppl.103

Abstract #

103

Poster Bd #

E20

Abstract Disclosures

Similar Posters

First Author: Marta Caporale

First Author: H. K. Lyerly

First Author: M. Morse

First Author: Jonathan Matthew Hernandez